Project Grant HT94252411034
Award Date
11/1/24
Completion Date
10/31/26
Dollars Obligated
$472K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
The U.S. Defense Health Agency awarded a $1,562,257 project grant under the Military Medical Research and Development program (CFDA 12.420) to The Ohio State University. The grant supports research to target de novo pyrimidine synthesis as a potential treatment for ovarian cancer. The project will involve collaboration between researchers at The Ohio State University and the University of South Florida, who will design experiments to investigate the role of pyrimidine synthesis in ovarian cancer...
The Department of the Army Medical Command awarded a $472,500 Project Grant (CFDA 12.420 - Military Medical Research and Development) to The Ohio State University to explore the role of CHD1L expression as an early event in high-grade serous ovarian cancer. This 2-year research project, with a performance period from June 1, 2024 to May 31, 2026, aims to advance the understanding of this form of ovarian cancer to support the development of improved diagnostic tools and treatments for military...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $551,250.00 to The Ohio State University to support research on PPP2R1B IN DEDIFFERENTIATED LIPOSARCOMA. The project will be performed in Columbus, OH and run from Sep 30, 2023 through Sep 29, 2026. The Ohio State University has a history of conducting biomedical research and providing clinical trial coordination services to federal agencies like the National...
This $1,144,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Oklahoma Health Sciences Center to develop a drug targeting ORP4 as a precision treatment for ovarian cancer. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative investigations spanning basic, applied, and translational domains....
The Ohio State University will receive $1,181,604 under a four-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The funding will support research into developing new methods to access extracellular vesicle MDM2 DNA cargo as a potential biomarker for liposarcoma. The grant aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for...
This Project Grant award, valued at $541,837.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at the University of Oklahoma Health Sciences Center, with the aim of developing a drug-targeting ORP4 as a precision ovarian cancer treatment. The award period runs from May 1, 2025 to April 30, 2029, leveraging the university's expertise in medical research and product development...
This $1,574,999.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Ohio State University to investigate SLIT2 as a novel approach for targeting metastatic breast cancer. The award period runs from June 15, 2025 to June 14, 2028. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical solutions to critical health...
This federal Project Grant award of $1,251,451 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) aims to support research on metastatic progression in medullary thyroid cancer. The award period runs from July 1, 2023 to June 30, 2027 and will be carried out by the prime awardee, The Ohio State University (OSU). Under the grant, OSU will conduct genomic sequencing studies and organoid/metastasis-on-a-chip studies to investigate...
The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
This federal Project Grant award of $1,317,976.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at The Ohio State University to target the RAL G proteins for the treatment of triple-negative breast cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical investigations in cancer treatment. The award has a performance period from...